Schader, Jana Felicitas
Wigger, Oliver
Fasser, Marie-Rosa
Calek, Anna-Katharina
Rohner, Ramon
Schuler, Anna
Hammer, Niels
Snedeker, Jess G.
Farshad, Mazda
Widmer, Jonas
Funding for this research was provided by:
University of Zurich
Article History
Received: 16 March 2026
Revised: 5 May 2026
Accepted: 1 June 2026
First Online: 22 June 2026
Declarations
:
: JFS receives research fellowship support by ETH MedLab Fellowship. MF reports being a consultant for Medacta, Arthrex, Zurimed and President of the Board of MovingSpine (Balgrist University Hospital Startup) and Board member of Artonis (Balgrist University Hospital Startup). JS receives royalties from Karl Storz Endoscopy GmbH and ZuriMED Technologies AG. Is an unpaid consultant for Octapharma AG and Novartis AG. Is a stock owner at ZuriMED Technologies AG. Is an employee at the University of Zurich, ETH Zurich and University Hospital Balgrist. A research council member at the Swiss National Science Foundation (SNSF) and a Scientific Advisory Board Member at the Swiss Center for Microelectronics (CSEM) and President of the Board of Directors at ZuriMED Technologies AG. JW is a shareholder of Balgrist University Startup (MovingSpine). All the other authors report no conflicts of interest.